网站主页>>>项目整合精选>>>项目整合精选>>>Gadoteridol, Gd(HP-DO3A), Gd-HP-DO3A, SQ-32692, ProHance

Gadoteridol, Gd(HP-DO3A), Gd-HP-DO3A, SQ-32692, ProHance

钆特醇Chemical Name: (?-[10-(2-Hydroxypropyl)-1,4,7,10-tetraazacyclodecane-1,4,7-triacetato(3-)-N1,N4,N7,N10,O1,O4,O7,O10]gadolinium; (?-[10-(2-Hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato[(3-)]gadolinium
CAS No. 120066-54-8
项目整合开发状态: Launched-1992
项目研究机构: Bristol-Myers Squibb (Originator), Altana Pharma (Licensee), Bracco (Licensee), Rovi (Licensee)
合成路线:The synthesis of gadoteridol is as follows:Compound (I) was reacted with DMF dimethylacetal to form the tricyclic intermediate (II).Following partial hydrolysis of (II),(III) was obtained and isolated in high quality and yield.(III) was reacted with tert-butyl bromoacetate in a basic media to obtain (IV),which was treated with aqueous sulfuric acid to effect removal of the tert-butyl and formyl protecting groups.(V) could be either crystallized or lyophilized.(V) was reacted with propylene oxide at pH 12 and excess propylene oxide was removed under vacuum upon completion of the reaction.(VI) was isolated by anion exchange chromatography with sulfate,and sulfate was then removed using a poly(4-vinylpyridine) resin.HP-DO3A was reacted with gadolinium oxide in water.Following concentration,excess gadolinium oxide was removed by filtration,and Gd(HP-DO3A)H2O was isolated by removing solvent.The product was then crystallized from methanol/acetone.
📌 参考资料/链接:
参考文献标题:Synthesis of nonionic gadolinium chelates useful as contrast agents for magnetic resonance imaging: 1,4,7 Tris(carboxymethyl)-10-substituted-1,4,7,10-tetraazacyclodecanes and their corresponding gadolinium chelates
文献作者:Emswiler,J.E.; Gaughan,G.T.; Delaney,E.J.; Prasad,J.S.; Tweedle,M.F.; Dischino,D.D.; Srivastava,S.K.
参考来源:Inorg Chem 1991,30(6),1265-9

📄 详细内容


合成路线:The synthesis of gadoteridol is as follows:Compound (I) was reacted with DMF dimethylacetal to form the tricyclic intermediate (II).Following partial hydrolysis of (II),(III) was obtained and isolated in high quality and yield.(III) was reacted with tert-butyl bromoacetate in a basic media to obtain (IV),which was treated with aqueous sulfuric acid to effect removal of the tert-butyl and formyl protecting groups.(V) could be either crystallized or lyophilized.(V) was reacted with propylene oxide at pH 12 and excess propylene oxide was removed under vacuum upon completion of the reaction.(VI) was isolated by anion exchange chromatography with sulfate,and sulfate was then removed using a poly(4-vinylpyridine) resin.HP-DO3A was reacted with gadolinium oxide in water.Following concentration,excess gadolinium oxide was removed by filtration,and Gd(HP-DO3A)H2O was isolated by removing solvent.The product was then crystallized from methanol/acetone.
参考文献标题:Gadoteridol
文献作者:Runge,V.M.; Tweedle,M.F.
参考来源:Drugs Fut 1992,17(3),187


产品链接: CAS No. 120066-54-8››